Atlas Trials

Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119

Clinical trial NCT06504290 · RECRUITING

Trial details

NCT number
NCT06504290
Sponsor
Vigonvita Life Sciences
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2024-07-16
Primary completion
2026-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.